Market revenue in 2023 | USD 328.6 million |
Market revenue in 2030 | USD 443.3 million |
Growth rate | 4.4% (CAGR from 2023 to 2030) |
Largest segment | Biologics |
Fastest growing segment | Biologics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications |
Key market players worldwide | ConvaTec Group PLC, 3M Co, Coloplast A/S ADR, Smith & Nephew PLC, Medtronic PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic foot ulcer treatment market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 36.46% in 2023. Horizon Databook has segmented the Latin America diabetic foot ulcer treatment market based on wound care dressings, biologics, therapy devices, antibiotic medications covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America diabetic foot ulcer treatment market is primarily driven by developments in Brazil, Mexico, Argentina, and Colombia. Growing investments by market players in the region, proximity to North America, and free-trade agreements with major countries such as the U.S., Canada, Japan, & several European countries are anticipated to boost the Latin America market during the forecast period.
Latin America consists of countries with large populations, and most of these countries are in economic transition. This region has a younger age distribution compared to North America, and a growing population has been diagnosed with type I and type II diabetes. In 2021, mortality due to diabetes in the region was 410,000.
Increasing awareness about the disease has led to a substantial increase in the diagnosis of diabetic foot ulcers. Major investments by key market players in emerging economies and the presence of a large target population are factors expected to drive market growth. However, low affordability of advanced technologies by end users may hinder market growth in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America diabetic foot ulcer treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America diabetic foot ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account